P4 Medicine Update header 

    July 28, 2011

In This Issue

Benign or Cancerous? Gene Test Predicts Cancer Potential in Pancreatic Cysts  


NCHPEG to Hold 14th Annual Meeting  


Researchers Identify New Genetic Risk Factor for Sudden Cardiac Death


The Ghost of Personalized Medicine


Screening New Colon Cancer Patients for Lynch Syndrome Would Be Cost-Effective, Study Shows


P4 Medicine Update 7/11/11


Ohio State News and Events


$3.2 Million Awards Further Study of Air Pollution and Disease


Indirubin: Component  of Chinese Herbal Remedy Might Block Brain Tumor's Spread 


Omega-3 Reduces Anxiety and Inflammation in Healthy Students  


Ohio State Receives $1.4 Million for Burn Wound Care Research 


Ohio State Hosts Fourth Annual Personalized Health Care National Conference


 Stay connected. Follow us on Facebook Find us on Facebook 



Join the conversation today!.  

Visit our blog




Video: Ohio State Experts Discuss Investing in Health and Wellness


Read about Exclusive Personalized Medicine Program at Ohio State



Visit Ohio State's Center for Personalized Health Care site to learn more about P4 Medicine.




ISB logo 160 pixels wide


Coriell logo 160 pixels wide    

PMC logo 160 pixels wide 





Predict JPEG

Gene Test Predicts Cancer Potential in Pancreatic Cysts

Johns Hopkins scientists have developed a gene-based test to distinguish harmless from precancerous pancreatic cysts.  The test may eventually help some patients avoid needless surgery to remove the harmless variety. Read more...


National Coalition for Health Professional Education in Genetics to Hold 14th Annual Meeting, Sept. 26-27

With the theme "Strategies for Evidence-Based Education in Genetics" this year's meeting provides an opportunity for health professionals, educators, patient advocates and researchers to come together to learn about advances in genomics and the challenges and opportunities in the development, dissemination and evaluation of genomics education for diverse audiences. Please visit www.nchpeg.org for more information.


prevent icon wide

Researchers Identify New Genetic Risk Factor for Sudden Cardiac Death

Researchers have discovered a variation in the genome's DNA sequence that is linked to a significant increase in a person's risk of SCD. Understanding how genetic variation plays a role in the risk of SCD could eventually help those at risk take steps to prevent it, the researchers say, although they emphasize that a great deal of follow-up work is required. Read more...

                   Personalize JPEG

The Ghost of Personalized Medicine 

The US Food and Drug Administration recommends that doctors genotype patients before prescribing more than 70 commonly-used medications for specific genetic biomarkers. These tests, the agency suggests, can help physicians identify those in which the drug is less efficacious, poorly metabolized, or dangerous. But medicine is still far from a day when drugs and treatment regimes are fitted precisely to a patient's genomic profile. Read more... 


participate icon wideScreening New Colon Cancer Patients for Lynch Syndrome Would Be Cost-Effective, Study Shows

Screening every new colon cancer patient for a particular familial disorder extends lives at a reasonable cost, say Stanford University School of Medicine researchers. Lynch syndrome patients can take defensive steps (such as yearly colonoscopies) that can either prevent cancer or alert them to get cancer treatment early, when it has the best chance of working. Read more...  






Ohio State's Fourth Annual Personalized Health Care National Conference titled The Ralph and Johanna DeStefano Personalized Health Care Conference "The Future of P4 Medicine and Its Impact on Clinical Care" will be held October 6-7 at the Blackwell Inn, located on the campus of The Ohio State University.




A service brought to you by The Ohio State University Medical Center, "P4 Medicine Update" is a compilation of industry news and research developments relevant to the advancement of predictive, preventive, personalized and participatory medicine. 

The The Ohio State University Center for Personalized Health Care 
193 McCampbell Hall 1581 Dodd Dr. 

Columbus, OH 43210


To subscribe/unsubscribe, contact Sherri L. Kirk.



P4 Medicine Institute logo

Ohio State is a founding member of the P4 Medicine Institute (P4MI). P4MI is the world's only organization dedicated to accelerating the emergence and adoption of health care that is predictive, preventive, personalized and participatory.